Literature DB >> 15014295

Genetic diversity of Chlamydia trachomatis and the prevalence of trachoma.

Jianzhi Zhang1, Thomas Lietman, Lynn Olinger, Yinghui Miao, Richard S Stephens.   

Abstract

BACKGROUND: Considerable variation in the outer membrane protein (ompA) of Chlamydia trachomatis has been uncovered by immunotyping and, more recently, by genotyping. This diversity may assist Chlamydia in evading the human immune system; organisms may have a competitive advantage if they infect a host who has previously been infected only by other strains. If so, a diverse set of strains may attain a higher prevalence in a community than a single strain. We determined the predominant strains of ocular C. trachomatis in trachoma-endemic villages of Nepal and tested the hypothesis that strain diversity is associated with the prevalence of infection.
METHODS: Major outer membrane protein gene sequences of chlamydial isolates were determined from ligase chain reaction-positive eye swab samples collected from 10 villages. The diversity of genovars was determined for each village, using Simpson's index.
RESULTS: Two genovar families (Ba and C) and nine genovars were detected, with a single genovar (C1) comprising more than one-half of the samples. The prevalence of clinically active trachoma was significantly associated with the genetic diversity in a village, controlling for village size and number of samples taken in a village.
CONCLUSION: Genetic diversity of C. trachomatis is associated with the prevalence of infection in a community, consistent with the hypothesis that diversity may be necessary to attain a high prevalence in a community.

Entities:  

Mesh:

Year:  2004        PMID: 15014295     DOI: 10.1097/01.inf.0000115501.60397.a6

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  12 in total

1.  Detection by broad-range real-time PCR assay of Chlamydia species infecting human and animals.

Authors:  P Goldschmidt; H Rostane; M Sow; A Goépogui; L Batellier; C Chaumeil
Journal:  Br J Ophthalmol       Date:  2006-08-09       Impact factor: 4.638

2.  The epidemiological dynamics of infectious trachoma may facilitate elimination.

Authors:  Thomas M Lietman; Teshome Gebre; Berhan Ayele; Kathryn J Ray; M Cyrus Maher; Craig W See; Paul M Emerson; Travis C Porco
Journal:  Epidemics       Date:  2011-04-06       Impact factor: 4.396

3.  Combination antibiotics for the treatment of Chlamydia-induced reactive arthritis: is a cure in sight?

Authors:  John D Carter; Hervé C Gérard; Judith A Whittum-Hudson; Alan P Hudson
Journal:  Int J Clin Rheumtol       Date:  2011-06

4.  Patients with Chlamydia-associated arthritis have ocular (trachoma), not genital, serovars of C. trachomatis in synovial tissue.

Authors:  Hervé C Gerard; Jessica A Stanich; Judith A Whittum-Hudson; H Ralph Schumacher; John D Carter; Alan P Hudson
Journal:  Microb Pathog       Date:  2009-11-18       Impact factor: 3.738

5.  Diversity of Chlamydia trachomatis in Trachoma-Hyperendemic Communities Treated With Azithromycin.

Authors:  Stephanie A Chin; Daniel P Morberg; Wondu Alemayehu; Muluken Melese; Takele Lakew; Michael C Chen; Zhaoxia Zhou; Thuy Doan; Vicky Cevallos; Thomas M Lietman; Jeremy D Keenan
Journal:  Am J Epidemiol       Date:  2018-09-01       Impact factor: 4.897

6.  Importance of coverage and endemicity on the return of infectious trachoma after a single mass antibiotic distribution.

Authors:  Takele Lakew; Wondu Alemayehu; Muluken Melese; Elizabeth Yi; Jenafir I House; Kevin C Hong; Zhaoxia Zhou; Kathryn J Ray; Travis C Porco; Bruce D Gaynor; Thomas M Lietman; Jeremy D Keenan
Journal:  PLoS Negl Trop Dis       Date:  2009-08-25

7.  Assessment of transmission in trachoma programs over time suggests no short-term loss of immunity.

Authors:  Fengchen Liu; Travis C Porco; Kathryn J Ray; Robin L Bailey; Harran Mkocha; Beatriz Muñoz; Thomas C Quinn; Thomas M Lietman; Sheila K West
Journal:  PLoS Negl Trop Dis       Date:  2013-07-11

8.  Clinical and microbiological assessment of trachoma in the kolofata health district, far north region, cameroon.

Authors:  Pablo Goldschmidt; Djida Benallaoua; Abdou Amza; Ellen Einterz; Pierre Huguet; Francois Poisson; Aminou Bouba Bilinkai; Moustafa Ismaila; Philippe Bensaid; Lucienne Bella; Christine Chaumeil
Journal:  Trop Med Health       Date:  2012-04-04

9.  Chlamydia trachomatis ompA variants in trachoma: what do they tell us?

Authors:  Aura A Andreasen; Matthew J Burton; Martin J Holland; Spencer Polley; Nkoyo Faal; David C W Mabey; Robin L Bailey
Journal:  PLoS Negl Trop Dis       Date:  2008-09-24

10.  Reduction and return of infectious trachoma in severely affected communities in Ethiopia.

Authors:  Takele Lakew; Jenafir House; Kevin C Hong; Elizabeth Yi; Wondu Alemayehu; Muluken Melese; Zhaoxia Zhou; Kathryn Ray; Stephanie Chin; Emmanuel Romero; Jeremy Keenan; John P Whitcher; Bruce D Gaynor; Thomas M Lietman
Journal:  PLoS Negl Trop Dis       Date:  2009-02-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.